Ronald D. Krofft

1.4k total citations
18 papers, 1.1k citations indexed

About

Ronald D. Krofft is a scholar working on Nephrology, Molecular Biology and Genetics. According to data from OpenAlex, Ronald D. Krofft has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Nephrology, 11 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Ronald D. Krofft's work include Renal Diseases and Glomerulopathies (17 papers), Renal and related cancers (9 papers) and Chronic Kidney Disease and Diabetes (7 papers). Ronald D. Krofft is often cited by papers focused on Renal Diseases and Glomerulopathies (17 papers), Renal and related cancers (9 papers) and Chronic Kidney Disease and Diabetes (7 papers). Ronald D. Krofft collaborates with scholars based in United States, China and Germany. Ronald D. Krofft's co-authors include Stuart J. Shankland, Jeffrey W. Pippin, Paul T. Brinkkoetter, Takamoto Ohse, Caroline B. Marshall, Michael R. Vaughan, Zhihong Liu, Jiong Zhang, Christine M. Logar and Péter Hauser and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Kidney International.

In The Last Decade

Ronald D. Krofft

18 papers receiving 1.1k citations

Peers

Ronald D. Krofft
Caroline B. Marshall United States
Mohga El‐Abbadi United States
Alda Tufró United States
Mary Blonski United States
Xuefei Tian United States
Komal Vadnagara United States
Caroline B. Marshall United States
Ronald D. Krofft
Citations per year, relative to Ronald D. Krofft Ronald D. Krofft (= 1×) peers Caroline B. Marshall

Countries citing papers authored by Ronald D. Krofft

Since Specialization
Citations

This map shows the geographic impact of Ronald D. Krofft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald D. Krofft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald D. Krofft more than expected).

Fields of papers citing papers by Ronald D. Krofft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald D. Krofft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald D. Krofft. The network helps show where Ronald D. Krofft may publish in the future.

Co-authorship network of co-authors of Ronald D. Krofft

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald D. Krofft. A scholar is included among the top collaborators of Ronald D. Krofft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald D. Krofft. Ronald D. Krofft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pippin, Jeffrey W., Natalya Kaverina, Diana G. Eng, et al.. (2015). Cells of renin lineage are adult pluripotent progenitors in experimental glomerular disease. American Journal of Physiology-Renal Physiology. 309(4). F341–F358. 51 indexed citations
2.
Gharib, Sina A., et al.. (2014). Transcriptional Landscape of Glomerular Parietal Epithelial Cells. PLoS ONE. 9(8). e105289–e105289. 8 indexed citations
3.
Zhang, Jiong, David Yanez, Julia Lichtnekert, et al.. (2014). ACE-inhibition increases podocyte number in experimental glomerular disease independent of proliferation. Journal of the Renin-Angiotensin-Aldosterone System. 16(2). 234–248. 30 indexed citations
4.
Pippin, Jeffrey W., Sean T. Glenn, Ronald D. Krofft, et al.. (2014). Cells of renin lineage take on a podocyte phenotype in aging nephropathy. American Journal of Physiology-Renal Physiology. 306(10). F1198–F1209. 39 indexed citations
5.
Zhang, Jiong, et al.. (2013). Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS. American Journal of Physiology-Renal Physiology. 304(11). F1375–F1389. 85 indexed citations
6.
Zhang, Jiong, Jeffrey W. Pippin, Michael R. Vaughan, et al.. (2012). Retinoids Augment the Expression of Podocyte Proteins by Glomerular Parietal Epithelial Cells in Experimental Glomerular Disease. Nephron Experimental Nephrology. 121(1-2). e23–e37. 66 indexed citations
7.
Taniguchi, Yoshinori, Jeffrey W. Pippin, Henning Hagmann, et al.. (2012). Both cyclin I and p35 are required for maximal survival benefit of cyclin-dependent kinase 5 in kidney podocytes. American Journal of Physiology-Renal Physiology. 302(9). F1161–F1171. 24 indexed citations
8.
Zhang, Jiong, Kim M. Hansen, Jeffrey W. Pippin, et al.. (2011). De novo expression of podocyte proteins in parietal epithelial cells in experimental aging nephropathy. American Journal of Physiology-Renal Physiology. 302(5). F571–F580. 67 indexed citations
9.
Brinkkoetter, Paul T., Takamoto Ohse, Ronald D. Krofft, et al.. (2010). p35, the non-cyclin activator of Cdk5, protects podocytes against apoptosis in vitro and in vivo. Kidney International. 77(8). 690–699. 32 indexed citations
10.
Hauser, Péter, Jeffrey W. Pippin, Ronald D. Krofft, et al.. (2010). Novel siRNA Delivery System to Target Podocytes In Vivo. PLoS ONE. 5(3). e9463–e9463. 47 indexed citations
11.
Ohse, Takamoto, Jeffrey W. Pippin, Ronald D. Krofft, et al.. (2009). The enigmatic parietal epithelial cell is finally getting noticed: a review. Kidney International. 76(12). 1225–1238. 53 indexed citations
12.
Brinkkoetter, Paul T., Paul Olivier, Scott C. Henderson, et al.. (2009). Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cells. Journal of Clinical Investigation. 119(10). 3089–3101. 87 indexed citations
13.
Ohse, Takamoto, Michael R. Vaughan, Jeffrey B. Kopp, et al.. (2009). De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease. American Journal of Physiology-Renal Physiology. 298(3). F702–F711. 93 indexed citations
14.
Ohse, Takamoto, Jeffrey W. Pippin, Michael R. Vaughan, et al.. (2008). Establishment of Conditionally Immortalized Mouse Glomerular Parietal Epithelial Cells in Culture. Journal of the American Society of Nephrology. 19(10). 1879–1890. 69 indexed citations
15.
Pippin, Jeffrey W., Paul T. Brinkkoetter, Raghu Durvasula, et al.. (2008). Inducible rodent models of acquired podocyte diseases. American Journal of Physiology-Renal Physiology. 296(2). F213–F229. 210 indexed citations
16.
Logar, Christine M., Paul T. Brinkkoetter, Ronald D. Krofft, Jeffrey W. Pippin, & Stuart J. Shankland. (2007). Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo. Kidney International. 72(4). 489–498. 54 indexed citations
17.
Marshall, Caroline B., Jeffrey W. Pippin, Ronald D. Krofft, & Stuart J. Shankland. (2006). Puromycin aminonucleoside induces oxidant-dependent DNA damage in podocytes in vitro and in vivo. Kidney International. 70(11). 1962–1973. 91 indexed citations
18.
Griffin, Siân, Ronald D. Krofft, Jeffrey W. Pippin, & Stuart J. Shankland. (2005). Limitation of podocyte proliferation improves renal function in experimental crescentic glomerulonephritis. Kidney International. 67(3). 977–986. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026